USA002 — Lafayette, Indiana

USA002 is a clinical research site located in Lafayette, Indiana, United States 47905.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

USA002 has participated in 1 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer, Glioblastoma Multiforme.

Sponsors: Gan and Lee Pharmaceuticals, USA.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USA002?

USA002 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USA002 conducted?

USA002 has 1 clinical trials on record. Their work covers Non-small Cell Lung Cancer, Glioblastoma Multiforme.

Is USA002 accredited by Crixeo Health?

USA002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USA002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.